FDA-cleared profile

SurgicalAR

MEDIVIS, Inc. · Radiological images; modality varies or is not specified in FDA list · FDA-cleared (510(k))

Authorized purpose: SurgicalAR displays CT and MR medical images and associated data as two-dimensional, multiplanar, three-dimensional, or volume-rendered views on a workstation, touchscreen, or head-mounted display to support surgical planning and intraoperative review; headset and mobile views are informational and non-diagnostic.

Clinical role
Medical-image display, manipulation, three-dimensional visualization, measurement, and planning support.
Images and patients
Radiological images; modality varies or is not specified in FDA list · Multi-region
Key limitation
Keep in mind: Lossy compressed mammography images and digitized film screen images must not be reviewed for primary image interpretations. When accessing SurgicalAR from a wireless stereoscopic head-mounted display or mobile device, images viewed are for informational purposes only and not intended for diagnostic use.

Overview status: Source-reviewed overview

Report a correction
Clinical details Purpose, workflow fit, evidence, and safety record

Workflow navigation pilot

Workflow role has not yet been reviewed for this navigation pilot.

A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources

  • What does this software do?Authorized purpose: SurgicalAR displays CT and MR medical images and associated data as two-dimensional, multiplanar, three-dimensional, or volume-rendered views on a workstation, touchscreen, or head-mounted display to support surgical planning and intraoperative review; headset and mobile views are informational and non-diagnostic.
  • Which images or clinical context are in scope?Modality: Radiological images; modality varies or is not specified in FDA list Anatomy or clinical context: Multi-region Input: Patient CT/MR DICOM data.
  • Who uses it?Intended users: Radiologists, surgeons, physicians, technologists, and other trained clinical image users.
  • What does the software produce?Output: Display of medical images and other healthcare data, including image review, image manipulation, basic measurements, and 3D visualization with MPR reconstructions and 3D volume rendering.
  • What is its most important limitation?Key limitation: Lossy compressed mammography images and digitized film screen images must not be reviewed for primary image interpretations. When accessing SurgicalAR from a wireless stereoscopic head-mounted display or mobile device, images viewed are for informational purposes only and not intended for diagnostic use.

Clinical takeaway. Clinical role: SurgicalAR displays CT and MR medical images and associated data as two-dimensional, multiplanar, three-dimensional, or volume-rendered views on a workstation, touchscreen, or head-mounted display to support surgical planning and intraoperative review; headset and mobile views are informational and non-diagnostic.

Evidence takeaway. Evidence from the reviewed source record: The exact FDA document reports design verification, confirming that design output specifications met the design input requirements, and design validation including human factors and usability engineering testing of user interactions with the user interface, performed as simulated use; testing met all predetermined acceptance criteria. It reports no clinical study and no quantitative performance results. Results are as reported in the FDA submission, not independent validation.

Evidence context

Evidence context not reviewed for this FDA record.

Public-label constraints

Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.

Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.

Purpose
SurgicalAR displays CT and MR medical images and associated data as two-dimensional, multiplanar, three-dimensional, or volume-rendered views on a workstation, touchscreen, or head-mounted display to support surgical planning and intraoperative review; headset and mobile views are informational and non-diagnostic.
  • Exact FDA submission
  • Checked 2026-09-19

Clinical-use display mirrors the exact FDA-supported purpose reconciled from the decision-summary packet.

Workflow role
Medical-image display, manipulation, three-dimensional visualization, measurement, and planning support.
  • Exact FDA submission
  • Checked 2026-09-03
Required input
Patient CT/MR DICOM data.
  • Exact FDA submission
  • Checked 2026-09-19

The packet directly states the CT/MR DICOM input. Radiographic, fluoroscopic, and annotation-input wording in the current value is not established by the exact packet.

Output and clinician action
Display of medical images and other healthcare data, including image review, image manipulation, basic measurements, and 3D visualization with MPR reconstructions and 3D volume rendering.
  • Exact FDA submission
  • Checked 2026-09-19

The exact intended-use text supports display, review, manipulation, basic measurements, MPR, and 3D volume rendering; it does not state the current segmentation or registration outputs.

Care setting
Hospital, outpatient, operating-room, or clinical image-review environments.
  • Exact FDA submission
  • Checked 2026-09-03
Intended users
Radiologists, surgeons, physicians, technologists, and other trained clinical image users.
  • Exact FDA submission
  • Checked 2026-09-19

Exact FDA decision-summary packet reviewed on 2026-09-19; existing wording is supported without expansion.

Limitations
Lossy compressed mammography images and digitized film screen images must not be reviewed for primary image interpretations. When accessing SurgicalAR from a wireless stereoscopic head-mounted display or mobile device, images viewed are for informational purposes only and not intended for diagnostic use.
  • Exact FDA submission
  • Checked 2026-09-19

This replacement uses the packet's explicit mammography and HMD/mobile limitations and removes unsupported patient-identity, registration, and source-image review requirements.

Evidence summary
The exact FDA document reports design verification, confirming that design output specifications met the design input requirements, and design validation including human factors and usability engineering testing of user interactions with the user interface, performed as simulated use; testing met all predetermined acceptance criteria. It reports no clinical study and no quantitative performance results. Results are as reported in the FDA submission, not independent validation.
  • Exact FDA submission
  • Checked 2026-11-14

Packet wording: "Both design verification and design validation were successfully conducted as part of the testing for the SurgicalAR device." … "The purpose of the design verification activity was to ensure that the design output specifications met the design input requirements.". Read from the exact FDA decision document on 2026-11-14.

Evidence

Performance evidence

Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.

Evidence summary
The exact FDA document reports design verification, confirming that design output specifications met the design input requirements, and design validation including human factors and usability engineering testing of user interactions with the user interface, performed as simulated use; testing met all predetermined acceptance criteria. It reports no clinical study and no quantitative performance results. Results are as reported in the FDA submission, not independent validation.
  • FDA source
  • Exact FDA submission
  • Checked 2026-11-14

Packet wording: "Both design verification and design validation were successfully conducted as part of the testing for the SurgicalAR device." … "The purpose of the design verification activity was to ensure that the design output specifications met the design input requirements.". Read from the exact FDA decision document on 2026-11-14.

Reported sensitivity
Not applicable
  • Not applicable
  • Not applicable
  • Checked 2026-09-03

Sensitivity is not the primary endpoint for this system, reconstruction, segmentation, guidance, or quantitative function. Use the task-specific evidence below.

Reported specificity
Not applicable
  • Not applicable
  • Not applicable
  • Checked 2026-09-03

Specificity is not the primary endpoint for this system, reconstruction, segmentation, guidance, or quantitative function. Use the task-specific evidence below.

No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.

K190764 FDA performance package for SurgicalAR

  • DesignManufacturer DICOM, rendering, simulated-use, and human-factors validation
  • PopulationCT and MR surgical-planning or intraoperative image-review workflows with workstation, touchscreen, or headset display
  • Scopeexact submission
  • Tested versionSurgicalAR
  • IndependenceSponsor or vendor study

K190764

Manufacturer evidence submitted for FDA clearance or approval; local clinical, technical, and workflow acceptance remains necessary.

4 unlinked candidate evidence records are retained for source review and excluded from this evidence display.

Safety and lifecycle

Postmarket record

Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.

Postmarket safety review
The 2026-09-02 openFDA device-recall snapshot contained no record matched to K190764 by exact submission identifier. This does not exclude product-family, later, or adverse-event information.
  • Public source
  • Exact FDA submission
  • Checked 2026-09-03

Exact-identifier review does not prove absence of all product-family safety signals.

Pricing & contracts Public price, contract terms, and reimbursement

Price not public here; enter your quote

Not publicly available: Reviewed sources do not publish an exact-product procurement price with a stated offer scope.

Reimbursement

Reimbursement
No separate named-product Medicare payment was identified in the reviewed CMS coverage material. Evaluate the product within the applicable imaging, procedural, or surgical service line and verify payer, site-of-service, and coding assumptions independently.
  • Service-level, not product-specific
  • Checked 2026-09-03

No product-specific code

No separate named-product payment identified in reviewed public material

Centers for Medicare & Medicaid Services · United States

Build a local total-cost and value model; do not infer reimbursement from FDA clearance or approval.

IT implementation Deployment, interfaces, data handling, and support

System and version relationships

Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.

No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.

Review Merge, Visage, Sectra, AGFA and IntelePACS context

Integration chain: evidence at each hop

Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.

Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner

No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.

  1. Acquisition/source

    Source context, not route validation: Patient CT/MR DICOM data.

    Scope: Exact FDA submission. The packet directly states the CT/MR DICOM input. Radiographic, fluoroscopic, and annotation-input wording in the current value is not established by the exact packet.

    Confirm scanner/model, protocol, series completeness and both software builds.

    Field checked 2026-09-19 · FDA K190764: SurgicalAR

  2. Routing

    Source context, not route validation: DICOM import or network exchange with PACS, workstations, surgical systems, and archives; validate patient matching, display calibration, compression, export, and downtime.

    Scope: Product family. Current vendor materials are product-family evidence for K190764; confirm the exact cleared version, enabled options, deployment, and local compatibility.

    Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.

    Field checked 2026-09-03 · FDA K190764: SurgicalAR · Medivis SurgicalAR

  3. AI processing

    Source context, not route validation: Release-specific workstation, server, or connected display and headset configuration.

    Scope: Product family. Current vendor materials are product-family evidence for K190764; confirm the exact cleared version, enabled options, deployment, and local compatibility.

    Confirm processing location, queue ownership, exclusions and exact AI build.

    Field checked 2026-09-03 · FDA K190764: SurgicalAR · Medivis SurgicalAR

  4. Returned objects

    Source context, not route validation: Display of medical images and other healthcare data, including image review, image manipulation, basic measurements, and 3D visualization with MPR reconstructions and 3D volume rendering.

    Scope: Exact FDA submission. The exact intended-use text supports display, review, manipulation, basic measurements, MPR, and 3D volume rendering; it does not state the current segmentation or registration outputs.

    Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.

    Field checked 2026-09-19 · FDA K190764: SurgicalAR

  5. Viewer/worklist/report

    Unresolved route: Display of medical images and other healthcare data, including image review, image manipulation, basic measurements, and 3D visualization with MPR reconstructions and 3D volume rendering.

    Scope: Exact FDA submission. The exact intended-use text supports display, review, manipulation, basic measurements, MPR, and 3D volume rendering; it does not state the current segmentation or registration outputs.

    Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.

    Field checked 2026-09-19 · FDA K190764: SurgicalAR

  6. Support owner

    Unresolved route: Not established for the exact route.

    Scope: Scope not established.

    Name the local, platform and AI supplier support owners and escalation path.

Planned local route tests

No tests below have been performed or accepted.

  1. Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
  2. Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
  3. Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
  4. Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
  5. Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
  6. Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
  7. Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.

Local implementation checklist

Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.

Open the printable evaluation checklist

Deployment
Release-specific workstation, server, or connected display and headset configuration.
  • Product family
  • Checked 2026-09-03

Current vendor materials are product-family evidence for K190764; confirm the exact cleared version, enabled options, deployment, and local compatibility.

Integration
DICOM import or network exchange with PACS, workstations, surgical systems, and archives; validate patient matching, display calibration, compression, export, and downtime.
  • Product family
  • Checked 2026-09-03

Current vendor materials are product-family evidence for K190764; confirm the exact cleared version, enabled options, deployment, and local compatibility.

Training
Only radiologists, surgeons, physicians, technologists, and other trained clinical image users should operate or interpret the product. Local onboarding should cover the exact release, supported population, limitations, failure examples, escalation, downtime, and competency documentation.
  • Exact FDA submission
  • Checked 2026-09-03
Monitoring
Monitor by exact hardware, software, model, and algorithm version; patient population; anatomy; protocol; operator; input quality; output edits or overrides; failed studies; repeat acquisition or rework; downstream impact; downtime; incidents; recalls; and updates. Track these product-specific limits: Head-mounted and mobile views are informational and non-diagnostic. Lossy-compressed mammography and digitized-film images are not for primary interpretation; the display, registration, patient identity, and source-image review must be checked before use.
  • Product family
  • Checked 2026-09-03

Current vendor materials are product-family evidence for K190764; confirm the exact cleared version, enabled options, deployment, and local compatibility.

Release and scope verification

Map the installed model, build, options, population, anatomy, inputs, outputs, and enabled AI functions to K190764 before acceptance.

exact submission · checked 2026-09-03

Later product-family features are not evidence that this cleared release includes them.

Interoperability acceptance

DICOM import or network exchange with PACS, workstations, surgical systems, and archives; validate patient matching, display calibration, compression, export, and downtime.

product family · checked 2026-09-03

Test representative identifiers, orientation, geometry, measurements, units, routing, failure handling, and round trips locally. Vendor statements are current product-family context; confirm the exact cleared release and installed options.

Clinical acceptance

Use a signed local test set for the supported population and workflow. Include common and difficult cases, exclusions, acquisition variation, failed or low-quality inputs, reviewer overrides, and downstream effects. Head-mounted and mobile views are informational and non-diagnostic. Lossy-compressed mammography and digitized-film images are not for primary interpretation; the display, registration, patient identity, and source-image review must be checked before use.

exact submission · checked 2026-09-03

Define stop-use, escalation, rollback, and revalidation triggers before production use.

Economic evaluation

Model capital and recurring cost against net staff time after review, throughput, repeat imaging or rework, room time, consumables, infrastructure, training, service, downtime, upgrade, and replacement costs.

product family · checked 2026-09-03

No exact-product price was found in the reviewed public material; vendor productivity claims are scenario inputs, not guaranteed local savings.

Lifecycle monitoring

Monitor by exact hardware, software, model, and algorithm version; patient population; anatomy; protocol; operator; input quality; output edits or overrides; failed studies; repeat acquisition or rework; downstream impact; downtime; incidents; recalls; and updates. Track these product-specific limits: Head-mounted and mobile views are informational and non-diagnostic. Lossy-compressed mammography and digitized-film images are not for primary interpretation; the display, registration, patient identity, and source-image review must be checked before use.

product family · checked 2026-09-03

Revalidate after material software, hardware, model, protocol, interface, or clinical-policy changes. Vendor statements are current product-family context; confirm the exact cleared release and installed options.

Sources & review details FDA identity, research record, source ledger, and history

Regulatory identity

FDA record and catalog context

The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.

FDA submission
K190764
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Modality
Radiological images; modality varies or is not specified in FDA list
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-19

The exact device description states that the software loads patient CT/MR DICOM data; it does not support the current statement that the modality is unspecified. Controlled directory display reconciled from exact FDA wording: CT/MR DICOM data. -> Radiological images; modality varies or is not specified in FDA list.

Anatomy
Multi-region
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-19

Exact FDA decision-summary packet reviewed on 2026-09-19; existing wording is supported without expansion.

Clearance type
510(k)
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Decision date
2019-05-13
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
FDA status
FDA-cleared
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31

Research record

What has been checked

This audit distinguishes completed source review from fields that have not yet been researched.

Exact FDA record reviewedStatus
2026-09-20Last searched
28Fields reviewed
14Source classes checked
5Screened PubMed leads
1Screened trial leads
0Unreviewed FDA recall leads

The refreshed discovery snapshot contains 5 PubMed and 1 ClinicalTrials.gov candidate records. Discovery metadata alone does not establish exact tested-product, version, population, and endpoint applicability, so all candidates remain quarantined and none was promoted. The current discovery snapshot contains 5 PubMed and 1 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.

Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.

Source classes: fda ai list, fda decision summary, fda decision material, vendor product page, peer reviewed literature, clinical trial registry, reimbursement policy, fda device recall, fda decision summary packet, literature index, trial registry, pubmed, clinical trials, openfda device recall

Field review details

Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.

  • Public pricing: Not publicly available - checked 2026-09-03 - Exact FDA submission

    No public list price for the exact cleared configuration was found. Obtain a written quote separating hardware or license basis, implementation, interfaces, infrastructure, training, service, upgrades, renewal, consumables, and exit costs.

  • Pricing model: Not yet reviewed
  • Setup and integration fees: Not yet reviewed
  • Recurring fees: Not yet reviewed
  • Minimum commitment: Not yet reviewed
  • Contract duration: Not yet reviewed
  • Renewal terms: Not yet reviewed
  • Cancellation terms: Not yet reviewed
  • Support and service terms: Not yet reviewed
  • Trial or pilot terms: Not yet reviewed
  • Data hosting location: Not yet reviewed
  • Data retention: Not yet reviewed
  • Documented data use: Not yet reviewed
  • Hardware requirements: Not yet reviewed
  • Network requirements: Not yet reviewed
  • Identity and access: Not yet reviewed
  • Security: Not verified - checked 2026-09-03 - Exact FDA submission

    Public materials reviewed for this exact release do not establish the complete security posture. Request data-flow, identity, audit, encryption, retention, remote-access, vulnerability-management, backup, and incident-response evidence.

  • Installation timeline: Not yet reviewed

13 sources - 3 history items

Source ledger

  1. FDA K190764: SurgicalAR

    U.S. Food and Drug Administration - Published 2019-05-13 - Accessed 2026-09-19

    Scope: purpose, anatomy, intendedUsers, modality, input, output, limitations, evidenceSummary, clinicalUse

  2. Artificial Intelligence-Enabled Medical Devices

    U.S. Food and Drug Administration - Accessed 2026-08-31

    Scope: regulatoryIdentity, modalityContext

  3. PubMed biomedical literature index

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery

  4. ClinicalTrials.gov study registry

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery, studyStatus

  5. Medicare Coverage Database

    Centers for Medicare & Medicaid Services - Accessed 2026-09-01

    Scope: coverage, codingContext

  6. openFDA Device Recall API

    U.S. Food and Drug Administration - Accessed 2026-09-02

    Scope: recallDiscovery, nativeSubmissionMatching

  7. Medivis SurgicalAR

    Medivis - Accessed 2026-09-03

    Scope: productFamilyContext, workflowRole, implementationCapabilities

  8. Augmented Reality-Assisted Percutaneous Rhizotomy for Trigeminal Neuralgia.

    U.S. National Library of Medicine - Accessed 2026-09-03

    Scope: evidenceStudies, productFamilyContext, evidenceDiscovery

  9. Mixed Reality Surgical Navigation System; Positional Accuracy Based on Food and Drug Administration Standard.

    U.S. National Library of Medicine - Accessed 2026-09-03

    Scope: evidenceStudies, productFamilyContext, evidenceDiscovery

  10. Augmented reality-guided craniofacial and airway nerve block training for anesthesiology residents.

    U.S. National Library of Medicine - Accessed 2026-09-03

    Scope: evidenceStudies, productFamilyContext, evidenceDiscovery

  11. Mixed Reality in the Operating Room: An Initial Use in Frontal Sinus Setback in Gender-affirming Facial Surgery.

    U.S. National Library of Medicine - Accessed 2026-09-03

    Scope: evidenceStudies, productFamilyContext, evidenceDiscovery

  12. Optimizing the Workflow of Superficial Temporal Artery Mapping in Extracranial-Intracranial Bypass Surgery Using Mixed Reality: A Proof-of-Concept Study.

    U.S. National Library of Medicine - Accessed 2026-09-03

    Scope: evidenceStudies, productFamilyContext, evidenceDiscovery

  13. The Effect of AR in Patient Pre-operative Education

    U.S. National Library of Medicine - Accessed 2026-09-03

    Scope: evidenceStudies, productFamilyContext, evidenceDiscovery

Research history

  1. K190764 FDA decision

    Regulatory record

    510(k)

  2. Source-review record updated

    Research record

    fda record reviewed

  3. Reader overview source-reviewed

    Editorial review

    Source-reviewed editorial overlay

Alternatives

Related tools to compare

FDA-cleared K192455

Merge PACS

Merge Healthcare Incorporated

Authorized purpose: Merge PACS is a multi-modality image-management and diagnostic-viewing system for processing, displaying, communicating, reporting, printing, storing, and retrieving supported DICOM and related clinical images for radiologists, surgeons, referring physicians, and other authorized users.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Multi-region
Decision
2019-10-17
FDA-cleared K254207

AiORTA - Plan v2.0

ViTAA Medical Solutions, Inc.

Authorized purpose: AiORTA - Plan v2.0 is image-processing and analysis software for the labeled radiotherapy-planning workflow; exact modalities, structures, inputs, outputs, and user-review requirements remain submission-specific.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Multi-region
Decision
2026-03-30

Correct this exact record

Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.

Open existing correction destination

Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.

Accepted repository change history

No entry has been added to this scoped change history for this record. This is not proof that the record never changed.

Correction policy and limits · Public repository change history